Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Debarment hearings

Executive Summary

Former My-K Labs president Kun Chae Bae is requesting a hearing on FDA's March 30 proposal to permanently debar him from participating in the drug approval process. Bae was sentenced in December 1990 to three months work release and a $25,000 fine for making illegal payments totaling $30,000 to former FDA generic drugs branch chief Charles Chang and for giving gifts to a buyer for a Defense Personnel Support Center. Former Vitarine VP for manufacturing John Bushlow is asking for a hearing on FDA's Feb. 5 proposal to permanently debar him. Bushlow was sentenced in February 1992 to four months in jail for failing to establish and keep drug manufacturing records with intent to mislead.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS022607

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel